Mouthwash to fight cancer? Oral disinfectants induce apoptosis in human oral tumor cells

March 21, 2013

(Phys.org) —Patients who suffer from gingivitis are often advised to use disinfectant mouthwashes. In the future, the active ingredients in these products could be used in a completely different area: As scientists have reported in the journal Angewandte Chemie, Chlorhexidin and Alexidin increase programmed cell death and may be effective against cancers of the mouth and throat.

Sometimes researchers discover that established drugs have other effects in addition to those for which they were actually approved. For example acetylsalicylic acid (Aspirin) has commonly been used to treat pain and fever; more recently, however, it has also been prescribed to thrombosis-prone patients as a blood thinner. A team headed by Thorsten Berg is now convinced that many low-molecular drugs already in use demonstrate previously unrecognized activity toward interactions between proteins, which may be of therapeutic use.

The team of scientists from the University of Leipzig, the Max Planck Institute for Biochemistry, the Center for Integrated Protein Science Munich, the Helmholtz Center Munich, the Technical University Munich, and the ETH Zurich were out to use a protein– relevant for human health to demonstrate the interactions between two proteins whose interaction controls apoptosis, or programmed . Both proteins are from the same . The first protein, Bad, initiates apoptosis-promoting protein to inhibit it.

The researchers proceeded to screen a collection of over 4000 substances known as a compound library. The majority of the compounds in the library are small molecules in clinical use. Binding experiments were used to determine which of the substances inhibit the binding of the two . To determine the specificity of the "hits", their effects on other protein–protein interactions were also tested.

Berg and his co-workers were successful: Chlorhexidin, the active component in commercial oral such as Chlorhexamed, Chlorhexal, Periogard, Corsodyl, and Chlorohex; as well as Alexidin, the active component in Esemdent, both inhibit the binding of the apoptosis inhibitor to the apoptosis trigger. Chlorhexidin's effect is specific, while Alexidin has additional very weak effects on other proteins.

Why are apoptosis proteins interesting? Apoptosis is decreased in tumor cells, so the cells do not die off and continue to divide. One reason for this is that they produce too much of the apoptosis-inhibiting protein. In experiments with cultures of cells from various tongue and throat carcinomas, both compounds caused increased apoptosis. This effect is much stronger in the cancer cells than in healthy cells. It may be possible to use these drugs in therapeutic applications.

The researchers hope to find other protein-protein interactions that could be targeted with approved small-molecule drugs.

Explore further: Discovery could lead to new type of cancer treatment

More information: Berg, T. Oral Disinfectants Inhibit Protein–Protein Interactions Mediated by the Anti-Apoptotic Protein Bcl-xL and Induce Apoptosis in Human Oral Tumor Cells, Angewandte Chemie International Edition. dx.doi.org/10.1002/anie.201208889

Related Stories

New strategy directly activates cellular 'death protein'

May 31, 2012

Researchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells. They say the development could represent a new ...

Refusal of suicide order: Why tumor cells become resistant

June 23, 2008

Cells with irreparable DNA damage normally induce programmed cell death, or apoptosis. However, this mechanism often fails in tumor cells so that transformed cells are able to multiply and spread throughout the body. Scientists ...

A tricky tumor virus

January 17, 2008

Epstein-Barr virus (EBV) is a human-pathogenic virus which belongs to the herpes virus family. Almost every adult carries EBV inside. With an infestation rate of more than 90 %, EBV is one of the most successful human viruses. ...

Molecule's role in cancer suggests new combination therapy

March 1, 2012

Researchers at the University of Illinois at Chicago College of Medicine have found that a molecule found at elevated levels in cancer cells seems to protect them from the "cell-suicide" that is usually triggered by chemotherapy ...

Recommended for you

Fast, efficient sperm tails inspire nanobiotechnology

December 2, 2016

Just like workers in a factory, enzymes can create a final product more efficiently if they are stuck together in one place and pass the raw material from enzyme to enzyme, assembly line-style. That's according to scientists ...

Biodegradable polymers made by chemical vapor deposition

December 1, 2016

Polymerization by chemical vapor deposition (CVD) is a simple method for modifying surfaces by which topologically challenging substrates can be evenly coated with polymers. In the journal Angewandte Chemie, researchers have ...

Controlling chain conformations to enhance electronic devices

December 1, 2016

Controlling the way fluorinated polymer chains twist and turn may enable fast and flexible electrical circuits, according to collaborative research conducted at Penn State. The findings may offer substantial impact on the ...

New process produces hydrogen at much lower temperature

December 1, 2016

Waseda University researchers have developed a new method for producing hydrogen that is fast, irreversible, and takes place at much lower temperatures using less energy. This innovation is expected to contribute to the spread ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.